Physician profile
Greg Barry
NPI 1831536960
$438.15
in general payments reported to CMS, 2019-2025
11 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.53 · 2022: $15.32 · 2023: $17.15 · 2024: $136 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $120.89 | 2019-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $73.05 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $56.64 | 2024-2025 | Veozah |
| Glaxosmithkline, LLC. | $33.43 | 2024-2025 | Trelegy Ellipta |
| Pfizer INC. | $33.38 | 2024 | |
| Dynavax Technologies Corporation | $29.95 | 2022-2024 | Heplisav-B |
| Boston Scientific Corporation | $25.25 | 2025 | General - Pain Management |
| Merck Sharp & Dohme LLC | $21.75 | 2024 | Vaxneuvance, Gardasil 9, Capvaxive |
| Aimmune Therapeutics, INC. | $15.08 | 2024 | |
| Medtronic, INC. | $14.38 | 2025 | Inceptiv |
| Lilly USA, LLC | $14.35 | 2025 | Mounjaro, Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Barry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.